Sign in
8-K

Current Report

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-09-036770

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading v154450_8k.htm…